WO2025163592 - HIGH LEVEL PRODUCTION OF PEPTIDES AND PROTEINS
National phase entry is expected:
Publication Number
WO/2025/163592
Publication Date
07.08.2025
International Application No.
PCT/IB2025/051092
International Filing Date
31.01.2025
Title **
[English]
HIGH LEVEL PRODUCTION OF PEPTIDES AND PROTEINS
[French]
PRODUCTION DE PEPTIDES ET DE PROTÉINES À HAUT NIVEAU
Applicants **
SUN PHARMACEUTICAL INDUSTRIES LTD.
Inventors
MODY, Rustom
BOSE, Sandip
KARNWAL, Vaibhav
GUPTA, Shivika
ROY, Ajoy
Priority Data
202421006467
31.01.2024
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2512 | |
| EPO | Filing, Examination, Granting | 12040 | |
| Japan | Filing, Examination, Granting | 2307 | |
| South Korea | Filing, Examination, Granting | 2385 | |
| USA | Filing, Examination, Granting | 7740 |
Total:
26,984
Contact Us
Abstract[English]
This invention relates to multimers containing a plurality of target peptide sequences which permit high levels of expression and improved solubility for ease of downstream processing and purification.[French]
La présente invention concerne des multimères contenant une pluralité de séquences peptidiques cibles qui permettent des niveaux élevés d'expression et une solubilité améliorée pour une facilité de traitement et de purification en aval.